Skip to main content
. 2015 Jun 4;10:1053–1059. doi: 10.2147/COPD.S79864

Table 3.

Number of patients on none, single, double, or triple therapy in the groups based on GOLD spirometric grading

Grade I Grade II Grade III Grade IV
None (%) 38 (41) 51 (25) 10 (9) 4 (11)
Single (%) 36 (39) 77 (38) 33 (29) 1 (3)
Double (%) 7 (7) 46 (22) 33 (29) 14 (43)
Triple (%) 12 (13) 31 (15) 38 (33) 14 (43)

Abbreviation: GOLD, Global initiative for chronic Obstructive Lung Disease.